• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鼻窦肉瘤的治疗、结局及人口统计学特征:文献系统综述

Treatment, outcomes, and demographics in sinonasal sarcoma: a systematic review of the literature.

作者信息

Gore Mitchell R

机构信息

Syracuse, USA.

出版信息

BMC Ear Nose Throat Disord. 2018 Mar 21;18:4. doi: 10.1186/s12901-018-0052-5. eCollection 2018.

DOI:10.1186/s12901-018-0052-5
PMID:29581706
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5861608/
Abstract

BACKGROUND

Sarcomas comprise a diverse group of soft tissue mesenchymal malignancies. The sinuses and nasal region are a relatively rare site of sarcomas.

METHODS

Retrospective review of the literature on sinonasal sarcomas from 1987-2017. Data were analyzed for demographics, treatment type, stage, and histopathologic type. Kaplan-Meier analysis was used to assess and compare survival.

RESULTS

A total of 198 cases of sinonasal sarcoma were identified and analyzed. The median age at diagnosis was 39 years. Overall 5-, 10-, and 20-year survival was 61.3%, 58.9%, and 49.1%, respectively, and disease-free 5-, 10-, and 20-year survival was 53.2%, 49.1%, and 38.3%, respectively. Lymph node metastasis was present at diagnosis in 3.0% of cases, and distant metastasis was present in 3.5% of cases. On univariate analysis T stage, overall stage, treatment type, histopathologic subtype, and presence of distant metastasis significantly affected survival. On multivariate analysis overall stage alone significantly predicted overall survival. Open vs. endoscopic surgery, total radiation dose, and presence of neck metastasis did not significantly affect survival. Combined modality treatment was associated with higher survival rates than single modality therapy.

CONCLUSIONS

Sinonasal sarcoma is a relatively rare malignancy. Lower T and overall stage, lack of distant metastasis, and multimodality therapy were associated with improved survival. Certain histopathologic subtypes were associated with poorer survival.

摘要

背景

肉瘤是一组多样的软组织间叶性恶性肿瘤。鼻窦和鼻腔区域是肉瘤相对少见的发病部位。

方法

对1987年至2017年有关鼻窦肉瘤的文献进行回顾性分析。分析了人口统计学、治疗类型、分期和组织病理学类型等数据。采用Kaplan-Meier分析评估和比较生存率。

结果

共确定并分析了198例鼻窦肉瘤病例。诊断时的中位年龄为39岁。总体5年、10年和20年生存率分别为61.3%、58.9%和49.1%,无病5年、10年和20年生存率分别为53.2%、49.1%和38.3%。3.0%的病例在诊断时有淋巴结转移,3.5%的病例有远处转移。单因素分析显示,T分期、总体分期、治疗类型、组织病理学亚型和远处转移的存在对生存率有显著影响。多因素分析显示,仅总体分期可显著预测总生存率。开放手术与内镜手术、总放疗剂量以及颈部转移的存在对生存率无显著影响。综合治疗模式的生存率高于单一治疗模式。

结论

鼻窦肉瘤是一种相对少见的恶性肿瘤。较低的T分期和总体分期、无远处转移以及多模式治疗与生存率提高相关。某些组织病理学亚型与较差的生存率相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca31/5861608/d18633ede484/12901_2018_52_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca31/5861608/c988f11d12f3/12901_2018_52_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca31/5861608/eb76b79b9ea9/12901_2018_52_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca31/5861608/e6d1ff4b547b/12901_2018_52_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca31/5861608/11fcab4235dc/12901_2018_52_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca31/5861608/99ce71cb4209/12901_2018_52_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca31/5861608/2db20fcc531a/12901_2018_52_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca31/5861608/2b1d6252e64a/12901_2018_52_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca31/5861608/0d83d61f169e/12901_2018_52_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca31/5861608/308a37c84b08/12901_2018_52_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca31/5861608/1be6b8c88e5d/12901_2018_52_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca31/5861608/e2256d353da5/12901_2018_52_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca31/5861608/d18633ede484/12901_2018_52_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca31/5861608/c988f11d12f3/12901_2018_52_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca31/5861608/eb76b79b9ea9/12901_2018_52_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca31/5861608/e6d1ff4b547b/12901_2018_52_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca31/5861608/11fcab4235dc/12901_2018_52_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca31/5861608/99ce71cb4209/12901_2018_52_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca31/5861608/2db20fcc531a/12901_2018_52_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca31/5861608/2b1d6252e64a/12901_2018_52_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca31/5861608/0d83d61f169e/12901_2018_52_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca31/5861608/308a37c84b08/12901_2018_52_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca31/5861608/1be6b8c88e5d/12901_2018_52_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca31/5861608/e2256d353da5/12901_2018_52_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca31/5861608/d18633ede484/12901_2018_52_Fig12_HTML.jpg

相似文献

1
Treatment, outcomes, and demographics in sinonasal sarcoma: a systematic review of the literature.鼻窦肉瘤的治疗、结局及人口统计学特征:文献系统综述
BMC Ear Nose Throat Disord. 2018 Mar 21;18:4. doi: 10.1186/s12901-018-0052-5. eCollection 2018.
2
Survival in sinonasal and middle ear malignancies: a population-based study using the SEER 1973-2015 database.鼻窦和中耳恶性肿瘤的生存率:一项基于监测、流行病学和最终结果(SEER)1973 - 2015数据库的人群研究。
BMC Ear Nose Throat Disord. 2018 Aug 9;18:13. doi: 10.1186/s12901-018-0061-4. eCollection 2018.
3
Synovial Sarcoma Is Not Associated With a Higher Risk of Lymph Node Metastasis Compared With Other Soft Tissue Sarcomas.滑膜肉瘤与其他软组织肉瘤相比,淋巴结转移风险并无增加。
Clin Orthop Relat Res. 2018 Mar;476(3):589-598. doi: 10.1007/s11999.0000000000000057.
4
Clinical Implication of Diagnostic and Histopathologic Discrepancies in Sinonasal Malignancies.鼻窦恶性肿瘤诊断与组织病理学差异的临床意义。
Laryngoscope. 2021 May;131(5):E1468-E1475. doi: 10.1002/lary.29102. Epub 2020 Sep 18.
5
Sarcomas of the paranasal sinuses: An analysis of the SEER database.鼻窦肉瘤:美国监测、流行病学和最终结果(SEER)数据库分析
Laryngoscope Investig Otolaryngol. 2019 Jan 15;4(1):70-75. doi: 10.1002/lio2.245. eCollection 2019 Feb.
6
Treatment Outcomes and Prognostic Factors of Adult Sinonasal Sarcomas: A Single-Institution Case Series.成人鼻腔鼻窦肉瘤的治疗结果和预后因素:单机构病例系列。
Med Sci Monit. 2018 Sep 2;24:6113-6118. doi: 10.12659/MSM.909116.
7
A Population-Based Analysis of Survival for Sinonasal Rhabdomyosarcoma.一项基于人群的鼻窦横纹肌肉瘤生存分析。
Otolaryngol Head Neck Surg. 2017 Jul;157(1):142-149. doi: 10.1177/0194599817696292. Epub 2017 Apr 11.
8
Malignant transformation of sinonasal inverted papilloma: A retrospective analysis of 32 cases.鼻窦内翻性乳头状瘤的恶变:32例回顾性分析
Oncol Lett. 2014 Dec;8(6):2637-2641. doi: 10.3892/ol.2014.2539. Epub 2014 Sep 16.
9
Particle beam radiation therapy for sinonasal malignancies: Single institutional experience at the Shanghai Proton and Heavy Ion Center.粒子束放射治疗鼻窦恶性肿瘤:上海质子重离子中心的单机构经验。
Cancer Med. 2020 Nov;9(21):7914-7924. doi: 10.1002/cam4.3393. Epub 2020 Sep 25.
10
Treatment of Sinonasal Teratocarcinosarcoma: A Systematic Review and Survival Analysis.鼻腔鼻窦畸胎癌肉瘤的治疗:系统评价和生存分析。
Am J Rhinol Allergy. 2021 Jan;35(1):132-141. doi: 10.1177/1945892420959585. Epub 2020 Sep 20.

引用本文的文献

1
Efficacy of toripalimab in combination with anlotinib in recurrent undifferentiated pleomorphic sarcoma of the sinonasal region: a case report with biomarker analysis.托瑞帕利单抗联合安罗替尼治疗鼻窦区复发性未分化多形性肉瘤的疗效:一项生物标志物分析的病例报告
Front Immunol. 2025 May 9;16:1541209. doi: 10.3389/fimmu.2025.1541209. eCollection 2025.
2
Clinical Features and Prognostic Insights in Sinonasal Sarcomas: A 76-Case Single-Institution Experience.鼻窦肉瘤的临床特征与预后分析:单机构76例经验
Laryngoscope Investig Otolaryngol. 2025 Apr 22;10(2):e70145. doi: 10.1002/lio2.70145. eCollection 2025 Apr.
3

本文引用的文献

1
Outcomes in Adult Sinonasal Rhabdomyosarcoma.成人鼻窦横纹肌肉瘤的治疗结果
Otolaryngol Head Neck Surg. 2017 Jul;157(1):135-141. doi: 10.1177/0194599817696287. Epub 2017 Mar 14.
2
A Population-Based Analysis of Survival for Sinonasal Rhabdomyosarcoma.一项基于人群的鼻窦横纹肌肉瘤生存分析。
Otolaryngol Head Neck Surg. 2017 Jul;157(1):142-149. doi: 10.1177/0194599817696292. Epub 2017 Apr 11.
3
Imaging and Outcomes for a New Entity: Low-Grade Sinonasal Sarcoma with Neural and Myogenic Features.一种新实体的影像学表现及预后:具有神经和肌源性特征的低级别鼻窦肉瘤
Clinical course and vascular endothelial growth factor signaling system expression in maxillary angiosarcoma: A case report.
上颌窦血管肉瘤的临床病程和血管内皮生长因子信号系统表达:一例报告。
Sci Prog. 2024 Jul-Sep;107(3):368504241274022. doi: 10.1177/00368504241274022.
4
Angiosarcoma of the Maxillary Sinus: A Case Report.上颌窦血管肉瘤:一例报告
Cureus. 2024 Jun 25;16(6):e63131. doi: 10.7759/cureus.63131. eCollection 2024 Jun.
5
Highly Aggressive Osteosarcoma of the Ethmoids and Maxillary Sinus-A Case of Successful Surgery and Proton Beam Radiotherapy in a 65-Year-Old Man.额窦和上颌窦高度侵袭性骨肉瘤——65 岁男性成功手术和质子束放疗一例。
Medicina (Kaunas). 2022 Aug 23;58(9):1141. doi: 10.3390/medicina58091141.
6
Endoscopic endonasal resection of sinonasal teratocarcinosarcoma with intracranial breakthrough: illustrative case.经鼻内镜切除伴颅内侵犯的鼻窦畸胎癌肉瘤:病例报告
J Neurosurg Case Lessons. 2021 Oct 18;2(16):CASE21471. doi: 10.3171/CASE21471.
7
Multimodal Treatment With Orbital Organ Preservation in Adult Patients With Locally Advanced Small-Round-Cell Malignancy of the Nasal Cavity and Paranasal Sinus.鼻腔和鼻窦局部晚期小圆细胞恶性肿瘤成年患者眼眶器官保留的多模式治疗
Front Oncol. 2021 Apr 1;11:650385. doi: 10.3389/fonc.2021.650385. eCollection 2021.
8
Differences in the Inhibitory Specificity Distinguish the Efficacy of Plant Protease Inhibitors on Mouse Fibrosarcoma.抑制特异性的差异区分了植物蛋白酶抑制剂对小鼠纤维肉瘤的疗效。
Plants (Basel). 2021 Mar 23;10(3):602. doi: 10.3390/plants10030602.
9
Incidence and real-world burden of brain metastases from solid tumors and hematologic malignancies in Ontario: a population-based study.安大略省实体瘤和血液系统恶性肿瘤脑转移的发病率及真实世界负担:一项基于人群的研究。
Neurooncol Adv. 2020 Dec 22;3(1):vdaa178. doi: 10.1093/noajnl/vdaa178. eCollection 2021 Jan-Dec.
10
Head and neck sarcomas: imaging "pearls" and "mimics".头颈部肉瘤:影像学“珍珠”与“假象”。
Br J Radiol. 2021 Mar 1;94(1119):20200922. doi: 10.1259/bjr.20200922. Epub 2020 Nov 18.
J Neurol Surg Rep. 2017 Jan;78(1):e15-e19. doi: 10.1055/s-0037-1598198.
4
Image-guided interstitial high-dose-rate brachytherapy in the treatment of inoperable recurrent head and neck malignancies: An effective option of reirradiation.影像引导下组织间高剂量率近距离放射治疗不可手术切除的复发性头颈部恶性肿瘤:再程放疗的有效选择。
Head Neck. 2017 Apr;39(4):E61-E68. doi: 10.1002/hed.24697. Epub 2017 Feb 7.
5
Primary Ewing's sarcoma of the sinonasal tract in adults: A challenging disease.成人鼻窦原发性尤因肉瘤:一种具有挑战性的疾病。
Head Neck. 2017 Mar;39(3):E45-E50. doi: 10.1002/hed.24649. Epub 2016 Nov 29.
6
Adult onset sinonasal rhabdomyosarcoma - a rare case report with cytohistological features.成人鼻窦横纹肌肉瘤——一例具有细胞组织学特征的罕见病例报告
Malays J Pathol. 2016 Aug;38(2):169-73.
7
Head and neck sarcomas: clinical and histopathological presentation, treatment modalities, and outcomes.头颈部肉瘤:临床与组织病理学表现、治疗方式及治疗结果
J Laryngol Otol. 2016 Sep;130(9):850-9. doi: 10.1017/S0022215116008604. Epub 2016 Aug 1.
8
Multimodality Treatment in Ewing's Sarcoma Family Tumors of the Maxilla and Maxillary Sinus: Review of the Literature.上颌骨和上颌窦尤因肉瘤家族性肿瘤的多模态治疗:文献综述
Sarcoma. 2016;2016:3872768. doi: 10.1155/2016/3872768. Epub 2016 Jun 16.
9
Primary osteogenic osteosarcoma of the ethmoid sinus in an adolescent: case report.青少年筛窦原发性成骨性骨肉瘤:病例报告
J Radiol Case Rep. 2016 Feb 29;10(2):1-9. doi: 10.3941/jrcr.v10i2.2298. eCollection 2016 Feb.
10
YKL-40 protein in osteosarcoma tumor tissue.骨肉瘤肿瘤组织中的YKL-40蛋白
APMIS. 2016 Jun;124(6):453-61. doi: 10.1111/apm.12524. Epub 2016 Mar 14.